The ease of administration with new agents for schizophrenia via an injection is advantageous because this patient population is commonly agitated and difficult to administer oral medications to.
Katrianna Pranga, PharmD; John Burgess, PharmD, BCPS; Ron Welch, PharmD, BCPS, BCIDP
Advertisement
Articles by Katrianna Pranga, PharmD; John Burgess, PharmD, BCPS; Ron Welch, PharmD, BCPS, BCIDP
Advertisement
Latest Updated Articles
Clinical Overview: Updates in Pharmacologic Options for the Treatment of Schizophrenia, Bipolar DisorderPublished: June 13th 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
FDA Initiates Approval of Leucovorin for Patients With Cerebral Folate Deficiency
2
Rapid CAR T Expansion Linked to Delayed Neurotoxicity in Patients Treated With Cilta-Cel
3
Hercessi, Biosimilar to Herceptin, Shows Favorable Efficacy, Safety in Treating HER2+ MBC in Real-World Setting
4
IMS: Shaping the Future of Multiple Myeloma with Anti-CD38 Quadruplets
5
